Vantis Vascular has received FDA 510(k) clearance for a 6F version of its CrossFAST delivery system, expanding compatibility with intravascular imaging and calcium-modification devices. The November launch builds on encouraging early clinical experience, although comparative evidence remains limited.
Conavi Medical Corp. has announced a peer-reviewed case publication highlighting the use of its hybrid intravascular ultrasound and optical coherence tomography imaging system in a complex coronary intervention involving a patient with impaired renal function. The publication follows U.S. Food and Drug Administration 510(k) clearance for the Canadian medical device developer’s next-generation hybrid IVUS-OCT imaging
Cleerly's INVICTUS registry shows AI-QCT matches IVUS in coronary plaque quantification. Read the clinical analysis.